{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:43:54Z","timestamp":1787010234631,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Bickerstaff brainstem encephalitis (BBE) is a rare autoimmune neurological disorder first identified in 1951. It shares clinical and immunological features with Guillain\u2013Barr\u00e9 syndrome (GBS) and Miller\u2013Fisher syndrome (MFS). BBE, characterized by brainstem dysfunction, often after infection or vaccination, is characterized by immunopathogenesis involving microbial antigens and neural gangliosides, with anti-GQ1b IgG antibodies as key biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive narrative review was conducted by searching PubMed, Cochrane, Global Health Library, and Google Scholar for relevant literature up to 2025. Keywords included, \u201cBBE syndrome,\u201d \u201cMiller Fisher syndrome,\u201d \u201cGBS syndrome,\u201d \u201canti-GQ1b antibody syndrome,\u201d and \u201cautoimmune encephalitis.\u201d The Scale for the Assessment of Narrative Review Articles (SANRA) was utilized to ensure manuscript quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most cases of BBE have positive anti-GQ1b IgG antibodies, and the condition usually manifests as ophthalmoplegia, ataxia, and reduced consciousness. Cerebrospinal fluid examination frequently shows higher protein levels, and MRI results may reveal midbrain lesions. BBE, GBS, and MFS all have a pathogenic spectrum, which points to a continuum of post-infectious autoimmunity. Intravenous immunoglobulin (IVIG) and plasmapheresis are the main treatment approaches; both have been shown to be effective in reducing symptoms and hastening recovery. The use of corticosteroids as an adjuvant treatment is possible. Pediatric patients tend to heal more quickly, and the prognosis is generally good, however severe instances may necessitate intensive care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>BBE is a rare disorder requiring early recognition and immunotherapy. Detection of anti-GQ1b IgG antibodies differentiates it from other neurological conditions. Further research is needed for standardization and improved outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003587","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:15:19Z","timestamp":1754496919000},"page":"5122-5131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Bickerstaff encephalitis: a comprehensive narrative review of pathophysiology, clinical features, and global health considerations"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6878-2031","authenticated-orcid":false,"given":"Muhammad Shaheer Bin","family":"Faheem","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, Karachi Institute of Medical Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafila","family":"Zeeshan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Atta Ur Rafe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1510-1168","authenticated-orcid":false,"given":"Sumaya","family":"Samadi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kabul University of Medical Sciences \u201cAbu Ali Ibn Sina\u201d, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"1387505","DOI":"10.3389\/fneur.2024.1387505","article-title":"Bickerstaff encephalitis in childhood: a review of 74 cases in the literature from 1951 to today","volume":"15","author":"Giaccari","year":"2024","journal-title":"Front Neurol"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"2704\u201306","DOI":"10.1016\/j.radcr.2023.04.038","article-title":"Bickerstaff brainstem encephalitis: a case report","volume":"18","author":"Abide","year":"2023","journal-title":"Radiol Case Rep"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"143\u201346","DOI":"10.1016\/j.jneuroim.2008.02.011","article-title":"Bickerstaff\u2019s brainstem encephalitis after an outbreak of campylobacter jejuni enteritis","volume":"196","author":"Mori","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"1210\u201315","DOI":"10.1136\/jnnp-2012-303060","article-title":"Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics","volume":"83","author":"Koga","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"576\u201383","DOI":"10.1136\/jnnp-2012-302824","article-title":"Bickerstaff brainstem encephalitis and fisher syndrome: anti-GQ1b antibody syndrome","volume":"84","author":"Shahrizaila","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-021-02159-y","article-title":"Mother and son cases of Bickerstaff\u2019s brainstem encephalitis and fisher syndrome with serum anti-GQ1b IgG antibodies: a case report","volume":"21","author":"Natsui","year":"2021","journal-title":"BMC Neurol"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.clinme.2024.100113","article-title":"Bickerstaff\u2019s brainstem encephalitis: a diagnostic challenge","volume":"24","author":"Ali","year":"2024","journal-title":"Clin Med"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1\u20135","DOI":"10.1016\/j.jns.2010.12.010","article-title":"How do we identify infectious agents that trigger Guillain-Barr\u00e9 syndrome, fisher syndrome and Bickerstaff brainstem encephalitis?","volume":"302","author":"Yuki","year":"2011","journal-title":"J Neurol Sci"},{"key":"R9-20250806","first-page":"e55000","article-title":"Bickerstaff\u2019s Brainstem Encephalitis and Miller Fisher Syndrome: A Rare Overlap","volume":"16","author":"Pantbalekundri","year":"2024","journal-title":"Cureus"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"88\u201390","DOI":"10.1016\/S0022-510X(00)00379-8","article-title":"Treatment of Bickerstaff\u2019s brainstem encephalitis with immune globulin","volume":"178","author":"Fox","year":"2000","journal-title":"J Neurol Sci"},{"key":"R11-20250806","first-page":"100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R12-20250806","first-page":"478\u201393","article-title":"Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"key":"R13-20250806","first-page":"2127\u201333","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Database System Rev Implement Rep"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"138\u201350","DOI":"10.1016\/j.jclinepi.2020.09.018","article-title":"GRADE guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-an overview in the context of health decision-making","volume":"129","author":"Brozek","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12883-023-03239-x","article-title":"Immunopathogenesis of viral infections in neurological autoimmune disease","volume":"23","author":"Habibi","year":"2023","journal-title":"BMC Neurol"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00415-020-10201-1","article-title":"Bickerstaff encephalitis after COVID-19","volume":"268","author":"Llorente Ayuso","year":"2020","journal-title":"J Neurol"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"116576","DOI":"10.1016\/j.jns.2019.116576","article-title":"Antiganglioside antibodies in neurological diseases","volume":"408","author":"Wanleenuwat","year":"2020","journal-title":"J Neurol Sci"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1212\/NXI.0000000000000889","article-title":"Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody","volume":"7","author":"Yoshikawa","year":"2020","journal-title":"Neurol(R) Neuroimmunol & Neuroinflamm"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"391\u2013404","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"674\u201382","DOI":"10.1007\/s00415-008-0775-0","article-title":"Bickerstaff\u2019s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases","volume":"255","author":"Ito","year":"2008","journal-title":"J Neurol"},{"key":"R22-20250806","first-page":"363\u201367","article-title":"Clinical features of 19 children with Bickerstaff brainstem encephalitis","volume":"57","author":"Zhuo","year":"2019","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"e236545","DOI":"10.1136\/bcr-2020-236545","article-title":"Bickerstaff\u2019s brainstem encephalitis associated with anti-GM1 and anti-GD1a antibodies","volume":"13","author":"Cleaver","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"50\u201355","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"414\u201317","DOI":"10.1212\/WNL.43.2.414","article-title":"Frequent presence of anti-GQ1b antibody in fisher\u2019s syndrome","volume":"43","author":"Yuki","year":"1993","journal-title":"Neurology"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"1756285617722347","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-021-00968-y","article-title":"Management of pediatric post-infectious neurological syndromes","volume":"47","author":"Bozzola","year":"2021","journal-title":"Ital J Pediatr"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.mjafi.2013.05.011","article-title":"Intravenous immunoglobulin in pediatrics: a review","volume":"70","author":"Prasad","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"R29-20250806","doi-asserted-by":"crossref","first-page":"73\u201375","DOI":"10.1016\/S0887-8994(97)00141-0","article-title":"Brainstem involvement in a child with ophthalmoplegia, ataxia, areflexia syndrome","volume":"18","author":"Fargas","year":"1998","journal-title":"Pediatr Neurol"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"e41747","DOI":"10.1016\/j.heliyon.2025.e41747","article-title":"Efficacy of rituximab as second-line therapy for autoimmune encephalitis: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2025","journal-title":"Heliyon"},{"key":"R31-20250806","first-page":"e57993","article-title":"Utility of brainstem auditory evoked response as a diagnostic tool and rituximab as a treatment for severe Bickerstaff brainstem encephalitis: a case report","volume":"16","author":"Aninang","year":"2024","journal-title":"Cureus"},{"key":"R32-20250806","doi-asserted-by":"crossref","first-page":"1197\u2013208","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1212\/NXI.0000000000000514","article-title":"Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment","volume":"6","author":"Schubert","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R34-20250806","first-page":"12802\u201307","article-title":"Bickerstaff\u2019s brainstem encephalitis in childhood: a literature overview","volume":"25","author":"Marino","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R35-20250806","doi-asserted-by":"crossref","first-page":"509\u201313","DOI":"10.31083\/j.jin2002054","article-title":"On clinical findings of Bickerstaff\u2019s brainstem encephalitis in childhood","volume":"20","author":"Messina","year":"2021","journal-title":"J Integr Neurosci"},{"key":"R36-20250806","doi-asserted-by":"crossref","first-page":"14\u201316","DOI":"10.1097\/NRL.0000000000000255","article-title":"A probable case of recurrent Bickerstaff brainstem encephalitis with fulminant course in a pediatric patient","volume":"25","author":"Chamsi Basha","year":"2020","journal-title":"Neurologist"},{"key":"R37-20250806","first-page":"86","article-title":"Bickerstaff brainstem encephalitis \u2013 a serious disease with a favourable outcome","volume":"16","author":"Manjunath","year":"2019","journal-title":"Pediatr Oncall"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:15:24Z","timestamp":1754496924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003587","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"2025-04-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}